DC Field | Value | Language |
---|---|---|
dc.contributor.author | W Jin | - |
dc.contributor.author | B C Kim | - |
dc.contributor.author | C Tognon | - |
dc.contributor.author | Ho Jae Lee | - |
dc.contributor.author | S Patel | - |
dc.contributor.author | C L Lannon | - |
dc.contributor.author | J M Maris | - |
dc.contributor.author | T J Triche | - |
dc.contributor.author | P H B Sorensen | - |
dc.contributor.author | S J Kim | - |
dc.date.accessioned | 2017-04-19T09:03:37Z | - |
dc.date.available | 2017-04-19T09:03:37Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0027-8424 | - |
dc.identifier.uri | 10.1073/pnas.0503137102 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/7166 | - |
dc.description.abstract | An emerging theme in cancer biology is that although some malignancies occur through the sequential acquisition of different genetic alterations, certain dominantly acting oncoproteins such as those associated with chromosomal translocations have multiple functions and do not require additional mutations for cell transformation. The ETV6-NTRK3 (EN) chimeric tyrosine kinase, a potent oncoprotein expressed in tumors derived from multiple cell lineages, functions as a constitutively active protein tyrosine kinase. Here, we show that EN suppresses TGF-β signaling by directly binding to the type II TGF-β receptor, thereby preventing it from interacting with the type I TGF-β receptor. This activity requires a functional EN protein tyrosine kinase, and type II TGF-β receptor appears to be a direct target of EN. Our findings provide evidence for a previously undescribed mechanism by which oncogenic tyrosine kinases can block TGF-β tumor suppressor activity. | - |
dc.publisher | Natl Acad Sciences | - |
dc.title | The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-β signaling by inactivating the TGF-β type II receptor = ETV6-NTRK3 chimeric 타이로신 카이네이스의 TGF-β 2형 수용체 불활성화에 의한 TGF-β 2 | - |
dc.title.alternative | The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-β signaling by inactivating the TGF-β type II receptor | - |
dc.type | Article | - |
dc.citation.title | Proceedings of National Academy of Sciences of United States of America | - |
dc.citation.number | 45 | - |
dc.citation.endPage | 16244 | - |
dc.citation.startPage | 16239 | - |
dc.citation.volume | 102 | - |
dc.contributor.affiliatedAuthor | Ho Jae Lee | - |
dc.contributor.alternativeName | 진욱 | - |
dc.contributor.alternativeName | 김병철 | - |
dc.contributor.alternativeName | Tognon | - |
dc.contributor.alternativeName | 이호재 | - |
dc.contributor.alternativeName | Patel | - |
dc.contributor.alternativeName | Lannon | - |
dc.contributor.alternativeName | Maris | - |
dc.contributor.alternativeName | Triche | - |
dc.contributor.alternativeName | Sorensen | - |
dc.contributor.alternativeName | 김성진 | - |
dc.identifier.bibliographicCitation | Proceedings of National Academy of Sciences of United States of America, vol. 102, no. 45, pp. 16239-16244 | - |
dc.identifier.doi | 10.1073/pnas.0503137102 | - |
dc.subject.keyword | chromosomal translocation | - |
dc.subject.keyword | congenital fibrosarcoma | - |
dc.subject.keyword | TGF-β receptor | - |
dc.subject.local | chromosomal translocation | - |
dc.subject.local | congenital fibrosarcoma | - |
dc.subject.local | TGF-β receptor | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.